Based on the forecast data from 2024 to 2028, the use of respiratory system medicine in Belgium, measured in Units (Defined Daily Dosage) Per Thousand Persons Per Day, shows a slight downward trend. Starting at 103.9 in 2024, the value gradually decreases to 103.0 by 2028. This indicates a relatively stable but slightly declining consumption pattern.
Year-on-year, the variation in percentage showcases minimal declines:
- 2024 to 2025: -0.29%
- 2025 to 2026: -0.29%
- 2026 to 2027: -0.19%
- 2027 to 2028: -0.10%
Considering the previous two years, the overall change is minor. The Compound Annual Growth Rate (CAGR) over the last 5 years exhibits a small negative trend, reflecting an average annual decrease in the use of respiratory system medicine.
Looking ahead, key future trends to watch for include potential advancements in alternative treatments, shifts in disease prevalence due to changing environmental factors, and the impact of healthcare policies. Monitoring these factors will be crucial for understanding long-term usage patterns and market dynamics in respiratory system medicine in Belgium.
